Reply  by Hertzer, Norman R.
is a relative dearth of data in the literature with which to guide
therapy. A multicenter review of this uncommon problem is
needed to better clarify the potential risks and benefits of various
treatment options.
W. Charles Sternbergh III, MD
Ochsner Clinic
New Orleans, La
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Reply
We appreciate Dr Sternbergh’s response to our article and
the interesting perspective provided by his experience with two
additional patients, both of whom developed deep cervical infec-
tions caused by alpha-hemolytic streptococcus within 3 weeks
after carotid endarterectomy but were successfully treated by
antibiotics and local wound measures without excision of their
Dacron patches. Provided a satisfactory greater saphenous vein
had been present in either groin, we probably would have
replaced each of these patches with a vein patch simply because of
the traditional concern that antibiotics, debridement, and even
muscular coverage may not be sufficient to overcome bacterial
contamination in a fabric arterial prosthesis. While we agree that
early reoperations can be difficult, most of the morbidity in our
series that was mentioned by Dr Sternbergh—the two cranial
nerve injuries and a stroke related to preoperative angiography—
actually occurred in patients who presented with late patch infec-
tions and required reconstruction with vein grafts.
The surgical approach that was taken for the two early postop-
erative infections described by Dr Sternbergh brings to mind the
strategy that was introduced several years ago by Bandyk et al1 for
the management of late femoral graft biofilm infections caused by
Staphylococcus epidermidis, another organism that generally has low
clinical virulence. This strategy also emphasizes adequate debride-
ment and coverage with viable muscle—in this case, the sartorius—
but one of its important principles is replacement of all infected
Dacron with nonporous polytetrafluorethylene (PTFE) in order to
avoid persistent bacterial colonization in the interstices of a fabric
graft. (It seems safe to say that an autogenous replacement graft
would be just as appropriate as PTFE, or even more so, if one hav-
ing an adequate diameter were available.) As Dr Sternbergh is the
first to point out, the fact that this principle was not followed in
either of his patients does not invalidate it. He made a value judg-
ment based on the conditions as he found them, and it appears to
have been correct. However, he undoubtedly followed both of
these patients very closely and was prepared to excise their Dacron
patches if there had been any evidence of lingering infection.
Norman R. Hertzer, MD
Department of Vascular Surgery
The Cleveland Clinic Foundation
Cleveland, Ohio
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Regarding “Management of leg ulcers in patients
with rheumatoid arthritis or systemic sclerosis: the
importance of concomitant arterial and venous
disease”
To the Editors:
In their recent paper, Hafner et al1 are to be commended for
their thorough vascular assessment of patients with rheumatolog-
ical disease who have a leg ulcer. Like ourselves,2 they found that
leg ulcers in RA often have a multifactorial etiology with little
clinical evidence of vasculitis. It is important to stress, however,
that serological evidence of systemic vasculitis such as hypocom-
plementemia or positive tests for antineutrophil cytoplasmic anti-
bodies are usually lacking in systemic rheumatoid vasculitis and
cannot be used to exclude this diagnosis. Clinical clues such as
nail-fold infarcts, pericarditis, mononeuritis multiplex, or marked
constitutional symptoms should be looked for. If found, patients
should be referred to a rheumatologist for consideration of
immunosuppressive therapy. The absence of these features, how-
ever, should prompt an assessment of large vessel function such as
the authors describe. We also have anecdotal evidence of appro-
priate vascular intervention leading to ulcer healing in RA and
support their call for a formal study of the effectiveness of surgi-
cal intervention in these patients when evidence of systemic vas-
culitis is absent.
Euan McRorie, MD, FRCP(Edin)
Rheumatic Diseases Unit
Western General Hospital
Edinburgh, UK
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We acknowledge Dr McRorie’s valuable comments in
response to our publication on leg ulcers in patients with rheuma-
toid arthritis or systemic sclerosis. Obviously, we agree that
patients with clinical signs of systemic vasculitis should be referred
to a rheumatologist for further assessment and, where appropri-
ate, for immunosuppressive therapy. Among the nine patients
with rheumatoid arthritis and leg ulcers presented in our paper,
none had signs of nail-fold infarcts, pericarditis, mononeuritis
multiplex, renal involvement, or other symptoms of systemic vas-
culitis. Several among them (4/9) received additional immuno-
suppressive therapy for their ulcers, without improvement. It was
remarkable that some of the patients (5/9) had never been sub-
jected to vascular assessment. Often the initial cause for leg ulcer-
ation in rheumatoid arthritis remains unclear and must be left to
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